Benmoxin

Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.[1][2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.[1][2]

Benmoxin
Benmoxin.svg
Clinical data
Routes of
administration
Oral
ATC code
  • None
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • N'-(1-phenylethyl)benzohydrazide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.028.745 Edit this at Wikidata
Chemical and physical data
FormulaC15H16N2O
Molar mass240.306 g·mol−1
3D model (JSmol)
  • O=C(NNC(c1ccccc1)C)c2ccccc2
  • InChI=1S/C15H16N2O/c1-12(13-8-4-2-5-9-13)16-17-15(18)14-10-6-3-7-11-14/h2-12,16H,1H3,(H,17,18) checkY
  • Key:BEWNZPMDJIGBED-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

See alsoEdit

ReferencesEdit

  1. ^ a b Ganellin CR, Triggle DJ (1996). Dictionary of Pharmacological Agents. 1–2. Chapman & Hall. p. 229. ISBN 0-9630096-0-5.
  2. ^ a b Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.